Elevance Health (ELV) Receivables - Other (2009 - 2026)

Elevance Health (ELV) has 18 years of Receivables - Other data on file, last reported at $6.2 billion in Q1 2026.

• Quarterly Receivables - Other fell 6.22% year-over-year to $6.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.2 billion (down 6.22% YoY) and the FY2025 annual result came in at $6.3 billion, up 4.84% from the prior year.
• Receivables - Other eased to $6.2 billion in Q1 2026 per ELV's latest filing, from $6.3 billion in the prior quarter.
• Across five years, Receivables - Other topped out at $7.7 billion in Q3 2025 and bottomed at $3.3 billion in Q1 2022.
• The 5-year median for Receivables - Other is $5.4 billion (2023), against an average of $5.4 billion.
• The widest annual swing landed in 2022, when Receivables - Other surged 186.53%; it then slipped 6.22% in 2026.
• Tracing ELV's Receivables - Other over 5 years: stood at $4.3 billion in 2022, then rose by 25.76% to $5.4 billion in 2023, then gained by 11.3% to $6.0 billion in 2024, then gained by 4.84% to $6.3 billion in 2025, then slipped by 2.22% to $6.2 billion in 2026.
• Per Business Quant, the three latest ELV Receivables - Other figures stand at $6.2 billion (Q1 2026), $6.3 billion (Q4 2025), and $7.7 billion (Q3 2025).

Peer Comparison